Description
A selective Plk1 inhibitor (IC50s = 3 and 6 nM in an enzymatic assay and H82 lung cancer cells, respectively); over 500-fold selective over a panel of 318 kinases; inhibits tumor growth in a mouse xenograft model; increases autophagy and mTOR phosphorylation in NB4 cells; induces apoptosis in cancer cell lines
Formal name: 4-[(9-cyclopentyl-7,7-difluoro-6,7,8,9-tetrahydro-5-methyl-6-oxo-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide
Synonyms:
Molecular weight: 543.6
CAS: 1062243-51-9
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|Plks||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Autophagy||Research Area|Cancer|Cell Death|Apoptosis||Research Area|Cancer|Cell Signaling|PLK Signaling||Research Area|Cell Biology|Cell Death|Apoptosis||Research Area|Cell Biology|Endomembrane System & Vesicular Trafficking|Autophagy